Psychopharmacology of Catatonia: A Tour D'horizon

Overview

Journal Psychopharmacol Bull

Specialty Pharmacology

Date 2025 Jan 2

PMID 39744410

Authors

Ahmed Naguy

Saxby Pridmore

Victoria Ozidu

Bibi Alamiri

Affiliations

Soon will be listed here.

Abstract

Since its first inception by Kahlbaum in relation to schizophrenia, Catatonia syndrome is currently believed to cut across many neuropsychiatric diagnoses. In this focussed review, authors touch briefly on prevalence of catatonia in psychiatric presentations, discuss clinical diagnosis, neurobiology, typology, and conclude with a psychopharmacological algorithm to treatment.

References

Aljuwaiser M, Alayadhi N, Ozidu V, Shafik Zakhari S, Rushdy R, Naguy A . Clinical Indications of Memantine in Psychiatry-Science or Art?. Psychopharmacol Bull. 2023; 53(1):30-38. PMC: 9981340. View

Naguy A, Alamiri B . Memantine for pediatric catatonia - Experience of Al-Manara CAP centre from Kuwait. Asian J Psychiatr. 2023; 84:103547. DOI: 10.1016/j.ajp.2023.103547. View

Naguy A, Pridmore S, Alamiri B . COVID delirium-psychopharmacological tips. CNS Spectr. 2021; 27(5):543-544. DOI: 10.1017/S1092852921000286. View

Suchandra H, Reddi V, Aandi Subramaniyam B, Muliyala K . Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting. Aust N Z J Psychiatry. 2020; 55(10):993-1004. DOI: 10.1177/0004867420968915. View

Fink M, Taylor M . The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci. 2002; 251 Suppl 1:I8-13. DOI: 10.1007/pl00014200. View

Javelot H, Michel B, Steiner R, Javelot T, Cottencin O . Zolpidem test and catatonia. J Clin Pharm Ther. 2015; 40(6):699-701. DOI: 10.1111/jcpt.12330. View

Narayanaswamy J, Tibrewal P, Zutshi A, Srinivasaraju R, Math S . Clinical predictors of response to treatment in catatonia. Gen Hosp Psychiatry. 2012; 34(3):312-6. DOI: 10.1016/j.genhosppsych.2012.01.011. View

Zilles D . Vagus Nerve Stimulation as a Treatment for Catatonia: A Hypothesis. Front Psychiatry. 2019; 10:86. PMC: 6402369. DOI: 10.3389/fpsyt.2019.00086. View

Naguy A, Alamiri B . Lithium Beyond Bipolar Mood Disorders: A Hope or Hype?. Prim Care Companion CNS Disord. 2022; 24(5). DOI: 10.4088/PCC.21br03109. View

10.

Sienaert P, Rooseleer J, De Fruyt J . Measuring catatonia: a systematic review of rating scales. J Affect Disord. 2011; 135(1-3):1-9. DOI: 10.1016/j.jad.2011.02.012. View

11.

Van Den Eede F, Sabbe B . Catatonia in psychiatric classification. Am J Psychiatry. 2004; 161(12):2327-8. DOI: 10.1176/appi.ajp.161.12.2327-a. View

12.

Ghaffarinejad A, Sadeghi M, Estilaee F, Zokaee Z . Periodic catatonia. Challenging diagnosis for psychiatrists. Neurosciences (Riyadh). 2012; 17(2):156-8. View

13.

Naguy A, Moodliar-Rensburg S, Alamiri B . Autoimmune encephalitis- A new psychiatric masquerader!. Asian J Psychiatr. 2020; 54:102253. DOI: 10.1016/j.ajp.2020.102253. View

14.

Connell J, Oldham M, Pandharipande P, Dittus R, Wilson A, Mart M . Malignant Catatonia: A Review for the Intensivist. J Intensive Care Med. 2022; 38(2):137-150. DOI: 10.1177/08850666221114303. View

15.

Solmi M, Pigato G, Roiter B, Guaglianone A, Martini L, Fornaro M . Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis. Schizophr Bull. 2017; 44(5):1133-1150. PMC: 6101628. DOI: 10.1093/schbul/sbx157. View

16.

Tang V, Duffin J . Catatonia in the History of Psychiatry: Construction and Deconstruction of a Disease Concept. Perspect Biol Med. 2015; 57(4):524-37. DOI: 10.1353/pbm.2014.0033. View

17.

Moskowitz A . "Scared stiff": catatonia as an evolutionary-based fear response. Psychol Rev. 2004; 111(4):984-1002. DOI: 10.1037/0033-295X.111.4.984. View

18.

Rogers J, Oldham M, Fricchione G, Northoff G, Wilson J, Mann S . Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023; 37(4):327-369. PMC: 10101189. DOI: 10.1177/02698811231158232. View

19.

Naguy A, Alenezi S, Alwetayan S . Acamprosate for Treatment-Refractory Catatonia. Am J Ther. 2019; 27(3):e324-e326. DOI: 10.1097/MJT.0000000000000991. View

20.

Edinoff A, Kaufman S, Hollier J, Virgen C, Karam C, Malone G . Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges. Neurol Int. 2021; 13(4):570-586. PMC: 8628989. DOI: 10.3390/neurolint13040057. View